|LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient|
Delivering optimized cardiac surgery perfusion for a wider patient population, the Inspire family of adult oxygenators helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, improving neurological protection and decreasing inflammatory response.
“LivaNova is committed to improving perfusion and patient outcomes,”
Since its formal launch in 2013 at the
"We have used the Inspire oxygenator in our daily practice since it was
released to optimize perfusion by reducing hemodilution and the need for
blood transfusions,” said
LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London, LivaNova has a presence in more than 100 countries worldwide.
The Company currently employs more than 4,500 employees, inclusive of
approximately 900 employed by our CRM business franchise.
LivaNova operates as three business franchises: Cardiac Surgery,
Neuromodulation and Cardiac Rhythm Management, with operating
headquarters in Mirandola (
Safe Harbor Statement
This news release may include certain statements concerning expectations
for the future that are forward-looking statements as defined by U.S.
federal law. Such forward-looking statements are subject to a variety of
known and unknown risks, uncertainties and other factors that are
difficult to predict and many of which are beyond management's control.
An extensive list of factors that can affect future results are
LivaNova PLC Investor Relations and Media